Pregabalin reduces post-surgical pain after thoracotomy: a prospective, randomized, controlled trial

Noriyuki Matsutani, Hitoshi Dejima, Yusuke Takahashi, Masafumi Kawamura

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: A new perioperative management method was explored by assessing the safety and the efficacy of pregabalin for the treatment of intercostal neuralgia after thoracotomy. Methods: The study was conducted on 68 adult patients scheduled to undergo thoracotomy. Patients were randomly divided into two groups; a NSAIDs group, where 34 patients were orally administered loxoprofen three times daily and a pregabalin group, where 34 patients were orally administered 75 mg of pregabalin twice daily, starting on the day of surgery and continuing for 2 weeks. The pain scores, sleep interference and the incidence of neuropathic pain were evaluated on days 1, 3 and 7, and at weeks 4, 8 and 12 after surgery. The frequency of pain medication use in the first week after surgery and the adverse effects in each group were also examined. Results: The pain scores, sleep interference and incidence of neuropathic pain were significantly lower (p < 0.001) at all time points in the pregabalin group. The use of additional pain medication during the first week after surgery was not significantly different between the groups. The only significant adverse effect was a stomach ache in the NSAIDs group, while mild drowsiness was reported in the pregabalin group. Conclusion: Pregabalin is considered to be an effective and safe drug for the treatment of pain after thoracotomy.

Original languageEnglish
Pages (from-to)1411-1416
Number of pages6
JournalSurgery Today
Volume45
Issue number11
DOIs
Publication statusPublished - 2015 Nov 1
Externally publishedYes

Fingerprint

Thoracotomy
Randomized Controlled Trials
Pain
Neuralgia
Non-Steroidal Anti-Inflammatory Agents
Sleep
Sleep Stages
Incidence
Ambulatory Surgical Procedures
Pregabalin
Stomach
Safety
Pharmaceutical Preparations

Keywords

  • Intercostal pain
  • Postoperative pain
  • Pregabalin
  • Thoracotomy

ASJC Scopus subject areas

  • Surgery

Cite this

Pregabalin reduces post-surgical pain after thoracotomy : a prospective, randomized, controlled trial. / Matsutani, Noriyuki; Dejima, Hitoshi; Takahashi, Yusuke; Kawamura, Masafumi.

In: Surgery Today, Vol. 45, No. 11, 01.11.2015, p. 1411-1416.

Research output: Contribution to journalArticle

Matsutani, Noriyuki ; Dejima, Hitoshi ; Takahashi, Yusuke ; Kawamura, Masafumi. / Pregabalin reduces post-surgical pain after thoracotomy : a prospective, randomized, controlled trial. In: Surgery Today. 2015 ; Vol. 45, No. 11. pp. 1411-1416.
@article{dc0e290ba2eb48ceb2249961948ba858,
title = "Pregabalin reduces post-surgical pain after thoracotomy: a prospective, randomized, controlled trial",
abstract = "Purpose: A new perioperative management method was explored by assessing the safety and the efficacy of pregabalin for the treatment of intercostal neuralgia after thoracotomy. Methods: The study was conducted on 68 adult patients scheduled to undergo thoracotomy. Patients were randomly divided into two groups; a NSAIDs group, where 34 patients were orally administered loxoprofen three times daily and a pregabalin group, where 34 patients were orally administered 75 mg of pregabalin twice daily, starting on the day of surgery and continuing for 2 weeks. The pain scores, sleep interference and the incidence of neuropathic pain were evaluated on days 1, 3 and 7, and at weeks 4, 8 and 12 after surgery. The frequency of pain medication use in the first week after surgery and the adverse effects in each group were also examined. Results: The pain scores, sleep interference and incidence of neuropathic pain were significantly lower (p < 0.001) at all time points in the pregabalin group. The use of additional pain medication during the first week after surgery was not significantly different between the groups. The only significant adverse effect was a stomach ache in the NSAIDs group, while mild drowsiness was reported in the pregabalin group. Conclusion: Pregabalin is considered to be an effective and safe drug for the treatment of pain after thoracotomy.",
keywords = "Intercostal pain, Postoperative pain, Pregabalin, Thoracotomy",
author = "Noriyuki Matsutani and Hitoshi Dejima and Yusuke Takahashi and Masafumi Kawamura",
year = "2015",
month = "11",
day = "1",
doi = "10.1007/s00595-014-1088-9",
language = "English",
volume = "45",
pages = "1411--1416",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "11",

}

TY - JOUR

T1 - Pregabalin reduces post-surgical pain after thoracotomy

T2 - a prospective, randomized, controlled trial

AU - Matsutani, Noriyuki

AU - Dejima, Hitoshi

AU - Takahashi, Yusuke

AU - Kawamura, Masafumi

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Purpose: A new perioperative management method was explored by assessing the safety and the efficacy of pregabalin for the treatment of intercostal neuralgia after thoracotomy. Methods: The study was conducted on 68 adult patients scheduled to undergo thoracotomy. Patients were randomly divided into two groups; a NSAIDs group, where 34 patients were orally administered loxoprofen three times daily and a pregabalin group, where 34 patients were orally administered 75 mg of pregabalin twice daily, starting on the day of surgery and continuing for 2 weeks. The pain scores, sleep interference and the incidence of neuropathic pain were evaluated on days 1, 3 and 7, and at weeks 4, 8 and 12 after surgery. The frequency of pain medication use in the first week after surgery and the adverse effects in each group were also examined. Results: The pain scores, sleep interference and incidence of neuropathic pain were significantly lower (p < 0.001) at all time points in the pregabalin group. The use of additional pain medication during the first week after surgery was not significantly different between the groups. The only significant adverse effect was a stomach ache in the NSAIDs group, while mild drowsiness was reported in the pregabalin group. Conclusion: Pregabalin is considered to be an effective and safe drug for the treatment of pain after thoracotomy.

AB - Purpose: A new perioperative management method was explored by assessing the safety and the efficacy of pregabalin for the treatment of intercostal neuralgia after thoracotomy. Methods: The study was conducted on 68 adult patients scheduled to undergo thoracotomy. Patients were randomly divided into two groups; a NSAIDs group, where 34 patients were orally administered loxoprofen three times daily and a pregabalin group, where 34 patients were orally administered 75 mg of pregabalin twice daily, starting on the day of surgery and continuing for 2 weeks. The pain scores, sleep interference and the incidence of neuropathic pain were evaluated on days 1, 3 and 7, and at weeks 4, 8 and 12 after surgery. The frequency of pain medication use in the first week after surgery and the adverse effects in each group were also examined. Results: The pain scores, sleep interference and incidence of neuropathic pain were significantly lower (p < 0.001) at all time points in the pregabalin group. The use of additional pain medication during the first week after surgery was not significantly different between the groups. The only significant adverse effect was a stomach ache in the NSAIDs group, while mild drowsiness was reported in the pregabalin group. Conclusion: Pregabalin is considered to be an effective and safe drug for the treatment of pain after thoracotomy.

KW - Intercostal pain

KW - Postoperative pain

KW - Pregabalin

KW - Thoracotomy

UR - http://www.scopus.com/inward/record.url?scp=84945480642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945480642&partnerID=8YFLogxK

U2 - 10.1007/s00595-014-1088-9

DO - 10.1007/s00595-014-1088-9

M3 - Article

C2 - 25430812

AN - SCOPUS:84945480642

VL - 45

SP - 1411

EP - 1416

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 11

ER -